Literature DB >> 11011084

Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus.

C Goldmann1, N Stolte, T Nisslein, G Hunsmann, W Lüke, H Petry.   

Abstract

Recombinantly expressed VP1-virus-like particles (VP1-VLP) of human polyomavirus JC virus (JCV) were described recently as a new DNA transporter system. It was shown that DNA molecules could be packaged into VP1-VLP during a controlled chemical reassociation/dissociation process. In the present study VP1-VLP were studied as carriers for pharmaceutical substances. Propidium iodide (PI) was packaged into VP1-VLP as a reporter molecule. The PI-containing VP1-VLP could be detected directly by flow cytometry. The fluorescence intensity of the VP1-VLP depended strongly on the initial PI concentration. This packaging method is easy to handle and applicable to viruses and VP1-VLP which can be dissociated and reassociated chemically.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011084     DOI: 10.1016/s0166-0934(00)00226-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

2.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

3.  Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

Authors:  Pankaj Seth; Frank Diaz; Eugene O Major
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

4.  In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.

Authors:  Sandra Paola Sánchez-Rodríguez; Joana Valeria Enrriquez-Avila; Juan Miguel Soto-Fajardo; Carolina Peña-Montes; Ismael Bustos-Jaimes
Journal:  Mol Biotechnol       Date:  2015-04       Impact factor: 2.695

5.  Immune response modulation by recombinant peptides expressed in virus-like particles.

Authors:  E V Svirshchevskaya; L Alekseeva; A Marchenko; N Viskova; T M Andronova; S V Benevolenskii; V P Kurup
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

6.  In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles.

Authors:  Meng-Ing Chou; Yu-Fan Hsieh; Meilin Wang; Jinghua Tsai Chang; Deching Chang; Moncef Zouali; Gregory J Tsay
Journal:  J Biomed Sci       Date:  2010-06-24       Impact factor: 8.410

7.  Surface Modification of Protein Nanocontainers and Their Self-Directing Character in Polymer Blends.

Authors:  Merih Sengonul; Josef Ruzicka; Athula B Attygalle; Matthew Libera
Journal:  Polymer (Guildf)       Date:  2007-06-15       Impact factor: 4.430

8.  Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.

Authors:  Chun-Nun Chao; Yih-Leh Huang; Mien-Chun Lin; Chiung-Yao Fang; Cheng-Huang Shen; Pei-Lain Chen; Meilin Wang; Deching Chang; Chih-En Tseng
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

Review 9.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

10.  In Vivo siRNA Delivery Using JC Virus-like Particles Decreases the Expression of RANKL in Rats.

Authors:  Daniel B Hoffmann; Kai O Böker; Stefan Schneider; Ellen Eckermann-Felkl; Angelina Schuder; Marina Komrakova; Stephan Sehmisch; Jens Gruber
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-22       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.